Login / Signup

Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice.

Giulia BonaldoNicola Montanaronull AlbertoVaccheriDomenico Motola
Published in: European journal of clinical pharmacology (2021)
CRS represents the major problem with the administration of CAR-T therapies. Our analysis has not revealed new ADRs; however, it supports the safety profile of CAR-T with new data from real clinical setting.
Keyphrases
  • clinical practice
  • electronic health record
  • single cell
  • big data
  • machine learning
  • deep learning